Quarterly non-GAAP net income was $847m, an increase of 28% compared to same period an year ago. Annual non-GAAP net income $3 billion, an increase of 22% compared same period in 2008.
Quarterly non-GAAP operating income was $1.0 billion, up 41% compared with the fourth quarter of 2008. Quarterly GAAP operating income totaled $412m, compared with a loss of $412m.
Teva’s annual non-GAAP operating income was $3.9 billion, up 35%. Annual GAAP operating income totaled $2.4 billion, compared with $1.1 billion.
Shlomo Yanai, president and chief executive officer of Teva, said: “2009 was a very good year for Teva, a year in which our company delivered record-breaking sales and profits across all our geographies and major businesses.
“This was also a year of major strategic achievements, including the successful integration of Barr, a process which was completed less than a year after closing, and from which we expect to continue to derive significant synergies for many years to come.
“I believe that especially against the backdrop of a troubled world economy, our results this year demonstrate Teva’s agility and the strength of our balanced business model, which enable us to deliver continuous profitable growth year after year.”